---
figid: PMC9127324__fphar-13-895710-g007
figtitle: Roxadustat, a Hypoxia-Inducible Factor 1A Activator, Attenuates Both Long-
  and Short-Term Alcohol-Induced Alcoholic Liver Disease
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Adenoviridae
pmcid: PMC9127324
filename: fphar-13-895710-g007.jpg
figlink: /pmc/articles/PMC9127324/figure/F7/
number: F7
caption: Schematic diagram of the role of roxadustat in ALD. Roxadustat reduces long-
  and short-term alcohol-induced liver damage. Activation of HIF-1α ameliorates fatty
  acid accumulation by regulating SERBP1c and ChREBPα in acute ALD mice while improving
  the lipid metabolism through the PPARα pathway in chronic ALD mice. Roxadustat blocks
  the expression of long-term alcohol treatment-induced inflammatory cytokines TNF-α
  and IL-1β. Meanwhile, roxadustat reduces oxidative stress by reducing hepatic CYP2E1
  to keep ROS at a low level in those two mouse models. We indicate that roxadustat
  may be a potential drug for ALD.
papertitle: Roxadustat, a Hypoxia-Inducible Factor 1α Activator, Attenuates Both Long-
  and Short-Term Alcohol-Induced Alcoholic Liver Disease.
reftext: Yongyao Gao, et al. Front Pharmacol. 2022;13:895710.
year: '2022'
doi: 10.3389/fphar.2022.895710
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: ALD | roxadustat | fatty liver | HIF-1α | inflammation | oxidative stress
automl_pathway: 0.9352124
figid_alias: PMC9127324__F7
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9127324__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9127324__fphar-13-895710-g007.html
  '@type': Dataset
  description: Schematic diagram of the role of roxadustat in ALD. Roxadustat reduces
    long- and short-term alcohol-induced liver damage. Activation of HIF-1α ameliorates
    fatty acid accumulation by regulating SERBP1c and ChREBPα in acute ALD mice while
    improving the lipid metabolism through the PPARα pathway in chronic ALD mice.
    Roxadustat blocks the expression of long-term alcohol treatment-induced inflammatory
    cytokines TNF-α and IL-1β. Meanwhile, roxadustat reduces oxidative stress by reducing
    hepatic CYP2E1 to keep ROS at a low level in those two mouse models. We indicate
    that roxadustat may be a potential drug for ALD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hif1a
  - Fasn
  - Ppara
  - Tnf
  - Il13
  - HIF1A
  - FASN
  - PPARA
  - TNF
  - IL13
---
